MSDS
D0263011 v3.0
Conforms to USDOL OSHA 29CFR 1910.1200 HAZCOM
11. Toxicological information
Not available.
Information on the likely
routes of exposure
Inhalation
:
No known significant effects or critical hazards.
Harmful if swallowed.
:
Ingestion
Skin contact
:
No known significant effects or critical hazards.
May cause slight transient irritation.
:
Eye contact
No known significant effects or critical hazards.
General
:
No known significant effects or critical hazards.
Carcinogenicity
:
No known significant effects or critical hazards.
Mutagenicity
:
No known significant effects or critical hazards.
Teratogenicity
:
Developmental effects
:
No known significant effects or critical hazards.
Fertility effects
:
No known significant effects or critical hazards.
Symptoms related to the physical, chemical and toxicological characteristics
Skin contact
Ingestion
Inhalation
No specific data.
This product contains anticoagulants with an effect similar to that of warfarin. The
anticoagulant interferes with the synthesis of prothrombin. Significant exposure (e.g.
ingestion) can cause anticoagulation effects and could aggravate existing blood clotting
disorders.
No specific data.
:
:
:
Eye contact
:
Adverse symptoms may include the following:
irritation
redness
Potential chronic health effects
Delayed and immediate effects and also chronic effects from short and long term exposure
Numerical measures of toxicity
Not available.
Acute toxicity estimates
:
Not available.
Potential acute health effects
Potential immediate
effects
:
Not available.
Short term exposure
Potential delayed effects
:
Not available.
Potential immediate
effects
:
Not available.
Long term exposure
Potential delayed effects
:
Not available.
7/11
26/05/2015.
Date of issue
:
SDS #
FF8121078 (D0263011)
:
Code #
D0263011 v3.0
: